Home › Funds › T. Rowe Price › T. Rowe Price New Horizons Fund, Inc.
Fund family: T. Rowe Price · Filed by T. Rowe Price New Horizons Fund, Inc. (CIK 80248) · SEC series S000002106
Share classes and tickers: PRJIX (C000159684), PRNHX (C000005478), TRUZX (C000219323)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 2,537 with, 13 against, 0 abstentions (not counted as with management). Shareholder proposals: 4 FOR, 8 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as T. Rowe Price’s manager page (244,024 ballot items across 112 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | T. Rowe Price | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 87.7% | 2,420 | 93.7% | 208,710 |
| Backed environmental and social shareholder proposals at US companies | n/a | 4 | 2.6% | 3,333 |
Each ballot item this fund voted is set against the votes of the other T. Rowe Price funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most T. Rowe Price funds on 54 items (2.4% of the 2,248 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most T. Rowe Price funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Loar Holdings Inc. | 2026-06-02 | 3 wordings Election of Raja Bobbili, Alison Bomberg and Margaret (Peg) McGetrick as Class II directors, each to hold office until our annual meeting of stockholders in 2029 and until their successor is duly elected and qualified, or until their earlier death, resignation, or removal: Raja Bobbili | Withhold | FOR — 9 of 11 T. Rowe Price funds | Against | Passed (calculated), 98.6% support |
| Birkenstock Holding Plc | 2026-04-29 | Amend Articles of Association | For | AGAINST — 11 of 14 T. Rowe Price funds | For | — |
| Birkenstock Holding Plc | 2026-04-29 | Elect Director Ruth Kennedy | For | AGAINST — 11 of 14 T. Rowe Price funds | For | — |
| UL Solutions Inc. | 2026-05-20 | Election of Directors: Elisabeth Torstad | Withhold | FOR — 10 of 13 T. Rowe Price funds | Against | — |
| UL Solutions Inc. | 2026-05-20 | Election of Directors: George A. Williams | Withhold | FOR — 10 of 13 T. Rowe Price funds | Against | Elected, 99.7% support |
| UL Solutions Inc. | 2026-05-20 | Election of Directors: James M. Shannon | Withhold | FOR — 10 of 13 T. Rowe Price funds | Against | Elected, 99.8% support |
| UL Solutions Inc. | 2026-05-20 | Election of Directors: James P. Dollive | Withhold | FOR — 10 of 13 T. Rowe Price funds | Against | Elected, 99.6% support |
| UL Solutions Inc. | 2026-05-20 | Election of Directors: Marla C. Gottschalk | Withhold | FOR — 10 of 13 T. Rowe Price funds | Against | Elected, 99.8% support |
| UL Solutions Inc. | 2026-05-20 | Election of Directors: Sally Susman | Withhold | FOR — 10 of 13 T. Rowe Price funds | Against | Elected, 99.9% support |
| Cytokinetics, Incorporated | 2026-05-27 | 2 wordings Election of Class I Directors for terms expiring in 2029: Edward M. Kaye, M.D. | Withhold | FOR — 15 of 22 T. Rowe Price funds | Against | Passed (calculated), 97.0% support |
| Noble Corporation plc | 2026-04-29 | Authorization of the Board to Allot Shares without Rights of Pre-Emption. | Against | FOR — 7 of 9 T. Rowe Price funds | Against | Approved, 81.0% support |
| Noble Corporation plc | 2026-04-29 | Authorization of the Board to Allot Shares. | Against | FOR — 7 of 9 T. Rowe Price funds | Against | — |
| Mirion Technologies, Inc. | 2026-05-13 | Elect directors for a one-year term: Jody A. Markopoulos | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Passed (calculated), 100.0% support |
| Mirion Technologies, Inc. | 2026-05-13 | Elect directors for a one-year term: John W. Kuo | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Passed (calculated), 100.0% support |
| Mirion Technologies, Inc. | 2026-05-13 | Elect directors for a one-year term: Kenneth C. Bockhorst | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Passed (calculated), 100.0% support |
| Mirion Technologies, Inc. | 2026-05-13 | Elect directors for a one-year term: Lawrence D. Kingsley | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Passed (calculated), 100.0% support |
| Mirion Technologies, Inc. | 2026-05-13 | Elect directors for a one-year term: Robert A. Cascella | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Passed (calculated), 100.0% support |
| Mirion Technologies, Inc. | 2026-05-13 | Elect directors for a one-year term: Sheila Rege | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Passed (calculated), 100.0% support |
| Mirion Technologies, Inc. | 2026-05-13 | Elect directors for a one-year term: Steven W. Etzel | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Passed (calculated), 100.0% support |
| Mercury Systems, Inc. | 2025-10-22 | To elect three Class I directors nominated by the Board of Directors, each to serve for a three-year term, and in each case until their successors have been duly elected and qualified: Howard L. Lance | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | — |
| Mercury Systems, Inc. | 2025-10-22 | To elect three Class I directors nominated by the Board of Directors, each to serve for a three-year term, and in each case until their successors have been duly elected and qualified: Lisa S. Disbrow | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | — |
| Applied Optoelectronics, Inc. | 2026-06-04 | Class I Directors for Election: Che-Wei Lin | For | WITHHOLD — 7 of 9 T. Rowe Price funds | For | — |
| Applied Optoelectronics, Inc. | 2026-06-04 | Class I Directors for Election: Robert (Bob) Flanagan | For | WITHHOLD — 7 of 9 T. Rowe Price funds | For | — |
| Patrick Industries, Inc. | 2026-05-14 | To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Blake W. Augsburger | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Elected, 97.4% support |
| Patrick Industries, Inc. | 2026-05-14 | To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Denis G. Suggs | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Elected, 93.5% support |
| Company | Meeting | Item | This fund | Most T. Rowe Price funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Patrick Industries, Inc. | 2026-05-14 | To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: John A. Forbes | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Elected, 92.6% support |
| Patrick Industries, Inc. | 2026-05-14 | To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Joseph M. Cerulli | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Elected, 83.6% support |
| Patrick Industries, Inc. | 2026-05-14 | To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: M. Scott Welch | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Elected, 93.4% support |
| Patrick Industries, Inc. | 2026-05-14 | To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Michael A. Kitson | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Elected, 96.3% support |
| Patrick Industries, Inc. | 2026-05-14 | To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Natalie A. Brown | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Elected, 94.3% support |
| Patrick Industries, Inc. | 2026-05-14 | To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Todd M. Cleveland | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Elected, 96.5% support |
| Peloton Interactive, Inc. | 2025-12-09 | Election of Directors: Chris Bruzzo | For | WITHHOLD — 7 of 9 T. Rowe Price funds | For | Elected, 77.8% support |
| Root, Inc. | 2026-06-03 | To elect three Class III directors, Lawrence Hilsheimer, Alexander Timm and Douglas Ulman, each to hold office until our Annual Meeting of Stockholders in 2029: Lawrence Hilsheimer | For | AGAINST — 7 of 9 T. Rowe Price funds | For | Elected, 92.8% support |
| PBF Energy Inc. | 2026-04-28 | Election of Directors: Spencer Abraham | Against | FOR — 7 of 10 T. Rowe Price funds | Against | Elected, 89.4% support |
| Ambarella, Inc. | 2026-06-26 | Election of Directors: D. Jeffrey Richardson | Withhold | FOR — 7 of 10 T. Rowe Price funds | Against | Elected, 89.0% support |
| Ambarella, Inc. | 2026-06-26 | Election of Directors: Elizabeth M. Schwarting | Withhold | FOR — 7 of 10 T. Rowe Price funds | Against | Elected, 80.4% support |
| Oscar Health, Inc. | 2026-06-04 | Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: David Alexander Plouffe | Withhold | FOR — 8 of 12 T. Rowe Price funds | Against | Passed (calculated), 99.5% support |
| Oscar Health, Inc. | 2026-06-04 | Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: Siddhartha Sankaran | Withhold | FOR — 8 of 12 T. Rowe Price funds | Against | Passed (calculated), 99.7% support |
| Oscar Health, Inc. | 2026-06-04 | Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: William (Bill) J. Gassen III | Withhold | FOR — 8 of 12 T. Rowe Price funds | Against | Passed (calculated), 96.9% support |
| Bio-Techne Corporation | 2025-10-30 | Approve, on an advisory basis, the compensation of our executive officers. | For | AGAINST — 8 of 13 T. Rowe Price funds | For | Approved, 72.1% support |
| Dutch Bros Inc. | 2026-05-13 | Election of Directors: Todd Penegor | For | AGAINST — 10 of 17 T. Rowe Price funds | For | Elected, 91.7% support |
| Dutch Bros Inc. | 2026-05-13 | Election of Directors: Travis Boersma | For | AGAINST — 10 of 17 T. Rowe Price funds | For | Elected, 95.6% support |
| Marqeta, Inc. | 2026-06-10 | To approve an amendment to our Amended and Restated Certificate of Incorporation to provide for officer exculpation as permitted by Delaware law. | For | AGAINST — 7 of 11 T. Rowe Price funds | For | Passed (calculated), 78.7% support |
| Marqeta, Inc. | 2026-06-10 | To elect the four Class II nominees for director named in the accompanying proxy statement to hold office until the annual meeting of stockholders in 2029 and until their successors have been duly elected and qualified, or until such director's earlier death, resignation, or removal: Judson (Jud) Li | For | WITHHOLD — 7 of 11 T. Rowe Price funds | For | Passed (calculated), 92.2% support |
| Marqeta, Inc. | 2026-06-10 | To elect the four Class II nominees for director named in the accompanying proxy statement to hold office until the annual meeting of stockholders in 2029 and until their successors have been duly elected and qualified, or until such director's earlier death, resignation, or removal: Martha Cummings | For | WITHHOLD — 7 of 11 T. Rowe Price funds | For | Passed (calculated), 82.1% support |
| Marqeta, Inc. | 2026-06-10 | To elect the four Class II nominees for director named in the accompanying proxy statement to hold office until the annual meeting of stockholders in 2029 and until their successors have been duly elected and qualified, or until such director's earlier death, resignation, or removal: Najuma Atkinson | For | WITHHOLD — 7 of 11 T. Rowe Price funds | For | Passed (calculated), 87.8% support |
| Marqeta, Inc. | 2026-06-10 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. | For | AGAINST — 8 of 14 T. Rowe Price funds | For | Passed (calculated), 78.5% support |
| MapLight Therapeutics, Inc. | 2026-06-23 | To elect the three Class I Director nominees named in the Proxy Statement to serve until the 2029 annual meeting of our stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Martin Babler | For | WITHHOLD — 8 of 14 T. Rowe Price funds | For | — |
| Installed Building Products, Inc. | 2026-05-19 | Election of Directors to serve for three-year terms: Robert H. Schottenstein | Against | FOR — 7 of 12 T. Rowe Price funds | Against | Elected, 93.9% support |
| Xenon Pharmaceuticals Inc. | 2026-06-02 | To approve the Corporation's 2026 Equity Incentive Plan; | Against | FOR — 7 of 12 T. Rowe Price funds | Against | Approved, 68.0% support |
| Kodiak Sciences Inc. | 2026-06-02 | Elect three Class II directors nominated by our board and named in this proxy statement: Charles A. Bancroft | For | WITHHOLD — 8 of 15 T. Rowe Price funds | For | Elected, 78.7% support |
| Denali Therapeutics Inc. | 2026-06-03 | ELECTION OF DIRECTORS: David Schenkein, M.D. | For | WITHHOLD — 8 of 15 T. Rowe Price funds | For | Elected, 73.5% support |
| Denali Therapeutics Inc. | 2026-06-03 | ELECTION OF DIRECTORS: Jennifer Cook | For | WITHHOLD — 8 of 15 T. Rowe Price funds | For | Elected, 60.9% support |
| Impinj, Inc. | 2026-05-28 | Election of Directors: Steve Sanghi | For | AGAINST — 7 of 13 T. Rowe Price funds | For | Elected, 68.1% support |
Download all 54 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 82.6% of this fund’s 2,550 such votes could be given a sector; the other 444 (17.4%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Industrials | 456 | 5 | 1.1% |
| Health Care | 436 | 0 | 0.0% |
| Technology | 371 | 3 | 0.8% |
| Consumer Discretionary | 349 | 3 | 0.9% |
| Finance | 219 | 1 | 0.5% |
| Energy | 111 | 0 | 0.0% |
| Miscellaneous | 47 | 0 | 0.0% |
| Real Estate | 42 | 0 | 0.0% |
| Basic Materials | 37 | 0 | 0.0% |
| Utilities | 28 | 0 | 0.0% |
| Consumer Staples | 5 | 0 | 0.0% |
| Telecommunications | 5 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 1,655 | 0 |
| Audit-related | 295 | 0 |
| Say-on-Pay | 263 | 0 |
| Compensation | 118 | 0 |
| Corporate Governance | 104 | 9 |
| Capital Structure | 89 | 0 |
| Extraordinary Transactions | 23 | 0 |
| Other | 10 | 0 |
| Shareholder Rights and Defenses | 8 | 0 |
| Other Social Issues | 7 | 3 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| RBC Bearings Incorporated | September 4, 2025 | $348M | 6 | 0 |
| Natera, Inc. | June 11, 2026 | $290M | 8 | 0 |
| Lattice Semiconductor Corporation | May 1, 2026 | $272M | 10 | 0 |
| argenx SE | November 18, 2025 | $270M | 1 | 0 |
| Kymera Therapeutics, Inc. | June 24, 2026 | $245M | 6 | 0 |
| Guardant Health, Inc. | June 17, 2026 | $223M | 5 | 0 |
| Samsara Inc. | July 29, 2025 | $206M | 11 | 0 |
| argenx SE | May 6, 2026 | $206M | 12 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 6, 2026 | Entegris, Inc. | Stockholder Proposal: Providing stockholders the right to call special meetings of stockholders. Shareholder proposal | Against | For |
| July 23, 2025 | Booz Allen Hamilton Holding Corporation | Vote on a stockholder proposal regarding a report on political spending. Shareholder proposal | Against | For |
| May 20, 2026 | Reliance, Inc. | To consider a stockholder proposal requiring any director who fails to receive a majority vote to leave the board of directors within nine months. Shareholder proposal | Against | For |
| June 15, 2026 | Datadog, Inc. | The stockholder proposal, if properly presented at the Annual Meeting, requesting the adoption of a simple majority voting provision. Shareholder proposal | For | Against |
| June 3, 2026 | Power Integrations, Inc. | To consider, if properly presented at the Annual Meeting, a stockholder proposal related to the separation of the office of Chairman of the Board and the office of Chief Executive Officer. Shareholder proposal | Against | For |
| May 11, 2026 | MKS Inc. | A shareholder proposal to reduce the threshold percentage of shareholders required to call a special meeting of shareholders from 40% to 10%, if properly presented at the meeting. Shareholder proposal | Against | For |
| April 29, 2026 | Huntington Ingalls Industries, Inc. | Stockholder proposal requesting an annual report on the Company's political spending. Shareholder proposal | Against | For |
| April 29, 2026 | Huntsman Corporation | Stockholder proposal requesting an independent board chair policy. Shareholder proposal | Against | For |
| June 15, 2026 | HubSpot, Inc. | A stockholder proposal to change the Company's Sixth Amended and Restated Bylaws to allow 10% holders of the Company's stock the ability to call a special meeting; and Shareholder proposal | For | Against |
| June 16, 2026 | Five Below, Inc. | Shareholder proposal requesting that provisions in the Company's governance documents requiring greater than a simple majority shareholder vote be changed to a simple majority vote standard. Shareholder proposal | For | Against |
| May 1, 2026 | Zions Bancorporation, N.A. | To consider a shareholder proposal regarding "Report on Risks from Misalignment Between Company Policies and Customer Base." Shareholder proposal | Against | For |
| May 20, 2026 | Hyatt Hotels Corporation | Stockholder proposal requesting the issuance of a report analyzing whether Hyatt could disclose its overall plastics use. Shareholder proposal | For | Against |
Meetings with a proxy contest or competing nominees (1 in 2025-2026), and how the fund voted the items on its ballot.
2,573 ballot items at 307 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, T. Rowe Price New Horizons Fund, Inc. (PRJIX) voted at 307 shareholder meetings of 299 companies, on 2,573 ballot items in all. Where management made a recommendation, the fund followed it on 99.5% of the items and voted against it 13 times. Its most frequent area of disagreement was corporate governance (9 of its votes against management). It voted on 12 shareholder proposals. It voted FOR the board's own proposals less often than T. Rowe Price's funds as a whole (87.7% against 93.7%). It voted differently from most T. Rowe Price funds on 54 items. 1 of its meetings was contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of T. Rowe Price’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.